FARE’s Medical Director and Vice President of Health and Education, Dr. Kelly Cleary, to Join Expert Panel at FDA-Supported Duke-Margolis Institute for Health Policy Workshop on Expanding Epinephrine Access

McLEAN, Va.—Dec. 15, 2025—FARE (Food Allergy Research & Education) today announced its Medical Director and Vice President of Health and Education, Kelly Cleary, MD, FAAP, will serve as a panelist at a U.S. Food and Drug Administration (FDA) and the Duke-Margolis Institute for Health Policy meeting. The workshop will focus on expanding access to epinephrine. 

“Every day, people with food allergy face real barriers to obtaining and using the only medication that can save their lives during anaphylaxis,” said Sung Poblete, PhD, RN, CEO of FARE. “This event represents an important opportunity to bring visibility to those barriers to develop solutions that help the community of more than 33 million people in the U.S. living with food allergy.”

Dr. Cleary will participate in Session 3: Current Accessibility to Epinephrine for Treating Anaphylaxis, and will be joined by Linda Herbert, PhD, Children’s National Hospital; Charity Luiskutty, Food Allergy & Anaphylaxis Connection Team; Ruchi Gupta, MD, MPH, Director, Center for Food Allergy & Asthma Research (CFAAR), Northwestern University; and Christopher Warren, PhD, Northwestern University; moderated by Michael Pistiner, MD, MMSc, Massachusetts General Hospital for Children.

FARE’s work to improve epinephrine access has included the introduction and expansion of the FARE Neighborhoods Initiative (FNI), which provides resources for food allergy patients in underserved communities across the nation. Access to epinephrine is a clear issue, as shown by a 2024 FARE-conducted survey that spanned five FNI communities. Among 925 lower income households with at least one food allergy in the home, 52 percent received an epinephrine prescription with 88 percent having filled their prescription. Only 19 percent of those surveyed reported access to epinephrine within five minutes all or most of the time. 

FARE has also released public service announcement campaigns to improve the understanding of food allergy and the critical importance of getting a prescription and carrying epinephrine.

The workshop will be held on Dec. 16 from 9 a.m. to 4:30 p.m. ET.